Extrapolation in the development of paediatric medicines: examples from approvals for biological treatments for paediatric chronic immune-mediated inflammatory diseases

Anna M Stefanska; Dorota Distlerová; Joachim Musaus; Thorsten M Olski; Kristina Dunder; Tomas Salmonson; Dirk Mentzer; Jan Müller-Berghaus; Robert Hemmings; Richard Veselý

doi:10.1136/archdischild-2016-312259

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via RCPCH

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

For authors

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via RCPCH

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Citation Tools

Review

Extrapolation in the development of paediatric medicines: examples from approvals for biological treatments for paediatric chronic immune-mediated inflammatory diseases

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Stefanska AM, Distlerová D, Musaus J, et al

Extrapolation in the development of paediatric medicines: examples from approvals for biological treatments for paediatric chronic immune-mediated inflammatory diseases

Archives of Disease in Childhood 2017;102:952-957.

Log in using your username and password

Main menu

Log in using your username and password

You are here

Download to a citation manager

Read the full text or download the PDF:

Log in using your username and password